Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome

Ekaterina Chigrinova, Michael Mian, Marta Scandurra, Timothy Charles Greiner, Wing C. Chan, Julie Marie Vose, Giorgio Inghirami, Annalisa Chiappella, Luca Baldini, Maurilio Ponzoni, Andrés J M Ferreri, Silvia Franceschetti, Gianluca Gaidano, Alessandra Tucci, Fabio Facchetti, Thierry Lazure, Olivier Lambotte, Santiago Montes-Moreno, Miguel A. Piris, Josep Fr NomdedeuSilvia Uccella, Paola M V Rancoita, Ivo Kwee, Emanuele Zucca, Francesco Bertoni

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Bone marrow (BM) involvement in diffuse large B-cell lymphoma (DLBCL) can be morphologically discordant from the primary tumor. Concordant BM infiltration has been shown associated with a poorer outcome in patients treated with CHOP. In order to evaluate tumor-related factors leading to BM involvement in DLBCL, we performed an integrated analysis of i) genomic profiles obtained with a high-density genome wide SNP-based arrays ii) immunomorphological and iii) clinical data from 133 patients uniformly treated with R-CHOP. BM infiltration was found in 27 of 133 (20%) cases; and it was concordant in 18/27 (67%) cases. Concordant infiltration, but not discordant, influenced negatively OS, PFS and DFS and was associated with higher serum LDH, lower CR and higher PD rates. No association with cell of origin was found between BM+ and BM- DLBCL. As compared with BM- cases, BM+ DLBCL showed absence of 7q gain.

Original languageEnglish (US)
Pages (from-to)38-41
Number of pages4
JournalHematological Oncology
Volume29
Issue number1
DOIs
StatePublished - Mar 1 2011

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Bone Marrow
Single Nucleotide Polymorphism
Neoplasms
Genome
Bone and Bones
Serum

Keywords

  • Bone marrow
  • CGH
  • Chromosome 7
  • Lymphoma
  • Microarray
  • Prognosis
  • R-CHOP

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome. / Chigrinova, Ekaterina; Mian, Michael; Scandurra, Marta; Greiner, Timothy Charles; Chan, Wing C.; Vose, Julie Marie; Inghirami, Giorgio; Chiappella, Annalisa; Baldini, Luca; Ponzoni, Maurilio; Ferreri, Andrés J M; Franceschetti, Silvia; Gaidano, Gianluca; Tucci, Alessandra; Facchetti, Fabio; Lazure, Thierry; Lambotte, Olivier; Montes-Moreno, Santiago; Piris, Miguel A.; Nomdedeu, Josep Fr; Uccella, Silvia; Rancoita, Paola M V; Kwee, Ivo; Zucca, Emanuele; Bertoni, Francesco.

In: Hematological Oncology, Vol. 29, No. 1, 01.03.2011, p. 38-41.

Research output: Contribution to journalArticle

Chigrinova, E, Mian, M, Scandurra, M, Greiner, TC, Chan, WC, Vose, JM, Inghirami, G, Chiappella, A, Baldini, L, Ponzoni, M, Ferreri, AJM, Franceschetti, S, Gaidano, G, Tucci, A, Facchetti, F, Lazure, T, Lambotte, O, Montes-Moreno, S, Piris, MA, Nomdedeu, JF, Uccella, S, Rancoita, PMV, Kwee, I, Zucca, E & Bertoni, F 2011, 'Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome', Hematological Oncology, vol. 29, no. 1, pp. 38-41. https://doi.org/10.1002/hon.953
Chigrinova, Ekaterina ; Mian, Michael ; Scandurra, Marta ; Greiner, Timothy Charles ; Chan, Wing C. ; Vose, Julie Marie ; Inghirami, Giorgio ; Chiappella, Annalisa ; Baldini, Luca ; Ponzoni, Maurilio ; Ferreri, Andrés J M ; Franceschetti, Silvia ; Gaidano, Gianluca ; Tucci, Alessandra ; Facchetti, Fabio ; Lazure, Thierry ; Lambotte, Olivier ; Montes-Moreno, Santiago ; Piris, Miguel A. ; Nomdedeu, Josep Fr ; Uccella, Silvia ; Rancoita, Paola M V ; Kwee, Ivo ; Zucca, Emanuele ; Bertoni, Francesco. / Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome. In: Hematological Oncology. 2011 ; Vol. 29, No. 1. pp. 38-41.
@article{909cdbd9304c42a2a71cb3cac77c20b1,
title = "Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome",
abstract = "Bone marrow (BM) involvement in diffuse large B-cell lymphoma (DLBCL) can be morphologically discordant from the primary tumor. Concordant BM infiltration has been shown associated with a poorer outcome in patients treated with CHOP. In order to evaluate tumor-related factors leading to BM involvement in DLBCL, we performed an integrated analysis of i) genomic profiles obtained with a high-density genome wide SNP-based arrays ii) immunomorphological and iii) clinical data from 133 patients uniformly treated with R-CHOP. BM infiltration was found in 27 of 133 (20{\%}) cases; and it was concordant in 18/27 (67{\%}) cases. Concordant infiltration, but not discordant, influenced negatively OS, PFS and DFS and was associated with higher serum LDH, lower CR and higher PD rates. No association with cell of origin was found between BM+ and BM- DLBCL. As compared with BM- cases, BM+ DLBCL showed absence of 7q gain.",
keywords = "Bone marrow, CGH, Chromosome 7, Lymphoma, Microarray, Prognosis, R-CHOP",
author = "Ekaterina Chigrinova and Michael Mian and Marta Scandurra and Greiner, {Timothy Charles} and Chan, {Wing C.} and Vose, {Julie Marie} and Giorgio Inghirami and Annalisa Chiappella and Luca Baldini and Maurilio Ponzoni and Ferreri, {Andr{\'e}s J M} and Silvia Franceschetti and Gianluca Gaidano and Alessandra Tucci and Fabio Facchetti and Thierry Lazure and Olivier Lambotte and Santiago Montes-Moreno and Piris, {Miguel A.} and Nomdedeu, {Josep Fr} and Silvia Uccella and Rancoita, {Paola M V} and Ivo Kwee and Emanuele Zucca and Francesco Bertoni",
year = "2011",
month = "3",
day = "1",
doi = "10.1002/hon.953",
language = "English (US)",
volume = "29",
pages = "38--41",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome

AU - Chigrinova, Ekaterina

AU - Mian, Michael

AU - Scandurra, Marta

AU - Greiner, Timothy Charles

AU - Chan, Wing C.

AU - Vose, Julie Marie

AU - Inghirami, Giorgio

AU - Chiappella, Annalisa

AU - Baldini, Luca

AU - Ponzoni, Maurilio

AU - Ferreri, Andrés J M

AU - Franceschetti, Silvia

AU - Gaidano, Gianluca

AU - Tucci, Alessandra

AU - Facchetti, Fabio

AU - Lazure, Thierry

AU - Lambotte, Olivier

AU - Montes-Moreno, Santiago

AU - Piris, Miguel A.

AU - Nomdedeu, Josep Fr

AU - Uccella, Silvia

AU - Rancoita, Paola M V

AU - Kwee, Ivo

AU - Zucca, Emanuele

AU - Bertoni, Francesco

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Bone marrow (BM) involvement in diffuse large B-cell lymphoma (DLBCL) can be morphologically discordant from the primary tumor. Concordant BM infiltration has been shown associated with a poorer outcome in patients treated with CHOP. In order to evaluate tumor-related factors leading to BM involvement in DLBCL, we performed an integrated analysis of i) genomic profiles obtained with a high-density genome wide SNP-based arrays ii) immunomorphological and iii) clinical data from 133 patients uniformly treated with R-CHOP. BM infiltration was found in 27 of 133 (20%) cases; and it was concordant in 18/27 (67%) cases. Concordant infiltration, but not discordant, influenced negatively OS, PFS and DFS and was associated with higher serum LDH, lower CR and higher PD rates. No association with cell of origin was found between BM+ and BM- DLBCL. As compared with BM- cases, BM+ DLBCL showed absence of 7q gain.

AB - Bone marrow (BM) involvement in diffuse large B-cell lymphoma (DLBCL) can be morphologically discordant from the primary tumor. Concordant BM infiltration has been shown associated with a poorer outcome in patients treated with CHOP. In order to evaluate tumor-related factors leading to BM involvement in DLBCL, we performed an integrated analysis of i) genomic profiles obtained with a high-density genome wide SNP-based arrays ii) immunomorphological and iii) clinical data from 133 patients uniformly treated with R-CHOP. BM infiltration was found in 27 of 133 (20%) cases; and it was concordant in 18/27 (67%) cases. Concordant infiltration, but not discordant, influenced negatively OS, PFS and DFS and was associated with higher serum LDH, lower CR and higher PD rates. No association with cell of origin was found between BM+ and BM- DLBCL. As compared with BM- cases, BM+ DLBCL showed absence of 7q gain.

KW - Bone marrow

KW - CGH

KW - Chromosome 7

KW - Lymphoma

KW - Microarray

KW - Prognosis

KW - R-CHOP

UR - http://www.scopus.com/inward/record.url?scp=79952327188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952327188&partnerID=8YFLogxK

U2 - 10.1002/hon.953

DO - 10.1002/hon.953

M3 - Article

C2 - 20635329

AN - SCOPUS:79952327188

VL - 29

SP - 38

EP - 41

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

IS - 1

ER -